FdaApplication
NDA 020822
Identifiers
- fda_app_no: NDA020822
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 1998-07-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CELEXA | CITALOPRAM HYDROBROMIDE | EQ 60MG BASE | TABLET;ORAL |
| CELEXA | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET;ORAL |
| CELEXA | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET;ORAL |
| CELEXA | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET;ORAL |
4 products